SERUM LEVELS OF THE LOW-AFFINITY INTERLEUKIN-2 RECEPTOR MOLECULE (TAC) DURING IL-2 THERAPY REFLECT SYSTEMIC LYMPHOID MASS ACTIVATION

被引:1
作者
VOSS, SD
HANK, JA
NOBIS, CA
FISCH, P
SOSMAN, JA
SONDEL, PM
机构
[1] UNIV WISCONSIN, SCH MED, DEPT HUMAN ONCOL, MADISON, WI 53706 USA
[2] UNIV WISCONSIN, SCH MED, DEPT PEDIAT, MADISON, WI 53706 USA
[3] UNIV WISCONSIN, DEPT GENET, MADISON, WI 53706 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:261 / 269
页数:9
相关论文
共 47 条
[1]   AUGMENTATION OF THE ANTI-TUMOR THERAPEUTIC EFFICACY OF LONG-TERM CULTURED LYMPHOCYTES-T BY INVIVO ADMINISTRATION OF PURIFIED INTERLEUKIN-2 [J].
CHEEVER, MA ;
GREENBERG, PD ;
FEFER, A ;
GILLIS, S .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (04) :968-980
[2]   POTENTIAL USES OF INTERLEUKIN-2 IN CANCER-THERAPY [J].
CHEEVER, MA ;
THOMPSON, JA ;
PEACE, DJ ;
GREENBERG, PD .
IMMUNOBIOLOGY, 1986, 172 (3-5) :365-382
[3]   NONRESTRICTED CYTO-TOXICITY MEDIATED BY INTERLEUKIN-2-EXPANDED LEUKOCYTES IS INHIBITED BY ANTI-LFA-1 MONOCLONAL-ANTIBODIES (MOAB) BUT POTENTIATED BY ANTI-CD3 MOAB [J].
CHEN, BP ;
MALKOVSKY, M ;
HANK, JA ;
SONDEL, PM .
CELLULAR IMMUNOLOGY, 1987, 110 (02) :282-293
[4]   PLASMA INTERLEUKIN-2 RECEPTOR LEVELS IN RENAL-ALLOGRAFT RECIPIENTS [J].
COLVIN, RB ;
FULLER, TC ;
MACKEEN, L ;
KUNG, PC ;
IP, SH ;
COSIMI, AB .
CLINICAL IMMUNOLOGY AND IMMUNOPATHOLOGY, 1987, 43 (02) :273-276
[5]  
GREENBERG PD, 1984, J IMMUNOL, V133, P3401
[6]  
GREENE WC, 1987, CLIN RES, V35, P439
[8]   LYMPHOKINE-ACTIVATED KILLER CELL PHENOMENON - LYSIS OF NATURAL KILLER-RESISTANT FRESH SOLID TUMOR-CELLS BY INTERLEUKIN 2-ACTIVATED AUTOLOGOUS HUMAN PERIPHERAL-BLOOD LYMPHOCYTES [J].
GRIMM, EA ;
MAZUMDER, A ;
ZHANG, HZ ;
ROSENBERG, SA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1982, 155 (06) :1823-1841
[9]  
HANK JA, 1988, CANCER RES, V48, P1965
[10]   THE HUMAN INTERMEDIATE-AFFINITY INTERLEUKIN-2 RECEPTOR CONSISTS OF 2 DISTINCT, PARTIALLY HOMOLOGOUS GLYCOPROTEINS [J].
HERRMANN, T ;
DIAMANTSTEIN, T .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1988, 18 (07) :1051-1057